Stock comparison
Haemonetics
Harrow Health
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HAE
Haemonetics
Market cap
$2.98B
Sector
Healthcare
HROW
Harrow Health
Market cap
$1.23B
Sector
Healthcare
Overall winner
Harrow Health HROW
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HAE | HROW | Winner |
|---|---|---|---|
| Warren Buffett | 70B | 54C | HAE |
| Benjamin Graham | 85A | 73D | HAE |
| Philip Fisher |
Side-by-side metrics
| Metric | HAE | HROW |
|---|---|---|
| Market cap | $2.98B | $1.23B |
| P/E (TTM) | 24.8x | - |
| EV/EBIT | 14.1x | 35.2x |
| ROIC (TTM) | 8.37% | 8.55% |
| Gross margin | 55.74% | 74.11% |
| Net margin | 7.29% | -5.57% |
| Revenue CAGR 5y | 7.65% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HAE leads on
- Net margin7.29%vs -5.57%+176%
- Debt / Equity1.5xvs 10.5x+85%
- EV/EBIT14.1xvs 35.2x+60%
- Market cap$2.98Bvs $1.23B
More like HROW
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.